Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Gastroenterology

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ajg.2010.393PMID 20959816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Multiple serological biomarkers for colorectal cancer detection

  2010cited by this paper
• Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies.

  2009cited by this paper
• Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.

  2009cited by this paper
• Identification of Cystatin SN as a novel tumor marker for colorectal cancer.

  2009cited by this paper
• Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up

  2008cited by this paper
• Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.

  2008cited by this paper
• Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse

  2008cited by this paper
• Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.

  2008cited by this paper
• Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update

  2008cited by this paper
• DNA methylation biomarkers for blood-based colorectal cancer screening.

  2008cited by this paper
• Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

  2008cited by this paper
• Prognostic Value of LISCH7 mRNA in Plasma and Tumor of Colon Cancer Patients

  2007cited by this paper
• Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies

  2007cited by this paper
• Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review

  2007cited by this paper
• Multiple Molecular Markers as Predictors of Colorectal Cancer in Patients with Normal Perioperative Serum Carcinoembryonic Antigen Levels

  2007cited by this paper
• Preoperative serum levels of c-erbB-2 do not seem to be useful in management of patients with rectal cancer

  2006cited by this paper
• Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.

  2006cited by this paper
• Molecular Detection of Circulating Tumor Cells in the Peripheral Blood of Patients with Colorectal Cancer Using RT-PCR: Significance of the Prediction of Postoperative Metastasis

  2006cited by this paper
• Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients

  2006cited by this paper
• Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.

  2006cited by this paper
• Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.

  2006cited by this paper
• Preoperative Plasma Vascular Endothelial Growth Factor But Not Nitrite Is a Useful Complementary Tumor Marker in Patients With Colorectal Cancer

  2006cited by this paper
• A retrospective analysis of submissions, acceptance rate, open peer review operations, and prepublication bias of the multidisciplinary open access journal Head & Face Medicine

  2006cited by this paper
• Thymidylate Synthase Messenger RNA Expression in Plasma from Patients with Colon Cancer: Prognostic Potential

  2006cited by this paper
• Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method.

  2006cited by this paper
• Detection of Circulating CEA-IgM Complexes in Early Stage Colorectal Cancer

  2005cited by this paper
• Glutathione S-transferase activity in patients with cancer of the digestive tract

  2005cited by this paper
• Improved sensitivity in the diagnosis of gastro-intestinal tumors by fuzzy logic-based tumor marker profiles including the tumor M2-PK.

  2005cited by this paper
• Comparative analysis of cancer-associated antigen CA-195, CA19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer

  2005cited by this paper
• Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Quantitative Detection of Promoter Hypermethylation in Multiple Genes in the Serum of Patients with Colorectal Cancer

  2005cited by this paper
• Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.

  2005cited by this paper
• Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.

  2005cited by this paper
• Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.

  2005cited by this paper
• Prognostic value of soluble P‐selectin levels in colorectal cancer

  2004cited by this paper
• Molecular Detection of APC, K-ras, and p53 Mutations in the Serum of Colorectal Cancer Patients as Circulating Biomarkers

  2004cited by this paper
• Clinical Interest of the Combined Use of Serum CD26 and Alpha-L-Fucosidase in the Early Diagnosis of Colorectal Cancer

  2004cited by this paper
• Estimating the Probability of Cancer with Several Tumor Markers in Patients with Colorectal Disease

  2004cited by this paper
• Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.

  2004cited by this paper
• Diagnosis and Monitoring of Colorectal Cancer by L6 Blood Serum Polymerase Chain Reaction Is Superior to Carcinoembryonic Antigen–Enzyme-Linked Immunosorbent Assay

  2003cited by this paper
• Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.

  2002cited by this paper
• Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma

  2002cited by this paper
• CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.

  2002cited by this paper
• Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue

  2002cited by this paper
• Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.

  2001cited by this paper
• Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.

  2001cited by this paper
• Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.

  2001cited by this paper
• Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase‐polymerase chain reaction

  2001cited by this paper
• Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.

  2001cited by this paper
• Value of the Serum Alpha-L-Fucosidase Activity in the Diagnosis of Colorectal Cancer

  2000cited by this paper
• Molecular detection of blood‐borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease

  2000cited by this paper
• Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer.

  1999cited by this paper
• Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients

  1999cited by this paper
• Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.

  1998cited by this paper
• Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction.

  1998cited by this paper
• Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients

  1997cited by this paper
• Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.

  1997cited by this paper
• Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.

  1996cited by this paper
• Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?

  1995cited by this paper
• Preoperative serum levels of CEA and CA 242 in colorectal cancer.

  1995cited by this paper
• Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.

  1994cited by this paper
• Carcinoembryonic antigen (CEA) in serum and bile of colorectal cancer patients with or without detectable liver metastases.

  1994cited by this paper
• Application of cancer procoagulant as an early detection tumor marker

  1994cited by this paper
• Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.

  1993cited by this paper
• Monoclonal antibody 4D3 detects small intestinal mucin antigen (SIMA)—Glycoprotein in the serum of patients with colorectal cancer

  1993cited by this paper
• Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.

  1993cited by this paper
• TAG‐72 (CA 72‐4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer

  1993cited by this paper
• Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9.

  1992cited by this paper
• Clinical significance of tumor marker NCC-ST 439 in large bowel cancers

  1991cited by this paper
• Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.

  1991cited by this paper
• Failure of CA19-9 to detect asymptomatic colorectal carcinoma.

  1991cited by this paper
• Presence of villin, a tissue-specific cytoskeletal protein, in sera of patients and an initial clinical evaluation of its value for the diagnosis and follow-up of colorectal cancers.

  1990cited by this paper
• The application of leukocyte adherence inhibition assay to patients with colorectal cancer

  1989cited by this paper
• The significance of CA19-9 tumor antigen in the serum of patients with carcinomas.

  1985cited by this paper
• Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.

  1984cited by this paper
• Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.

  1984cited by this paper
• Clinical significance of the preoperative plasma carcinoembryonic antigen (CEA) level in patients with carcinoma of the large bowel

  1982cited by this paper
• Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer

  1979cited by this paper
• Detection and monitoring of serum p 53 antibodies in patients with colorectal cancer

  year unknowncited by this paper

• Serum Levels of BDNF in Patients with Adenoma and Colorectal Cancer

  2021cites this paper
• A high-throughput magneto-electrochemical array for the integrated isolation and profiling of extracellular vesicles from plasma

  2021cites this paper
• Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation

  2020cites this paper
• Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.

  2020cites this paper
• Evaluation of the Role of miRNA-21 Levels as a Potential Diagnostic Biomarker for Colorectal Cancer Associated with Prognosis

  2020cites this paper
• Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer

  2019cites this paper
• Fecal immunochemical tests in combination with blood tests for colorectal cancer and advanced adenoma detection—systematic review

  2018cites this paper
• Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review

  2017cites this paper
• Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting

  2016cites this paper
• Blood‐based screening for bowel cancer may not resolve suboptimal screening participation in Australia

  2016cites this paper
• Empirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false-positive findings.

  2016cites this paper
• Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer

  2016cites this paper
• EVALUATION OF NEW EPIGENETIC MARKERS SPG20, ITGA4 AND ALX4 IN PLASMA OF COLORECTAL CANCER PATIENTS

  2016cites this paper
• Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting

  2015cites this paper
• Colorectal Cancer Biomarkers: Where Are We Now?

  2015cites this paper
• Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting

  2015cites this paper
• Diagnostic Metabolomic Blood Tests for Endoluminal Gastrointestinal Cancer—A Systematic Review and Assessment of Quality

  2015cites this paper
• Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

  2015influential citation
• Analysis of 32 Blood-Based Protein Biomarkers for their Potential to Diagnose Colorectal Cancer

  2015cites this paper
• Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.

  2014cites this paper
• MicroRNAs: potential biomarkers for disease diagnosis.

  2014cites this paper
• Proteomic Signatures of the Colorectal Cancer Desmoplastic Invasion Front

  2014cites this paper
• Colorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelled.

  2014cites this paper
• Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

  2013cites this paper
• Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests.

  2013cites this paper
• COST-EFFECTIVENESS OF METHYLATED SEPTIN 9 DNA VS. CURRENT STRATEGIES

  2013cites this paper
• Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies

  2013cites this paper
• Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer

  2013cites this paper
• Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening

  2012cites this paper
• Similar fecal immunochemical test results in screening and referral colorectal cancer.

  2012cites this paper
• The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia.

  2012cites this paper
• An Integrated Magneto-Electrochemical Device for the Rapid An Integrated Magneto-Electrochemical Device for the Rapid Profiling of Tumour Extracellular Vesicles from Blood Plasma Profiling of Tumour Extracellular Vesicles from Blood Plasma

  year unknowncites this paper